On April 30 2021 Hauwei Technologies sponsored a program Great Minds Talk: How Far to Low-Carbon Living? The participants in this discussion were Lord Adair Turner, chair of the Energy Transitions Commission, Prof Steve Keen, Honorary Professor and Vice President Research, University College London, and Paul Scanlan, Chief Technology Officer, Huawei Carrier Business Group. The moderator is Rebecca Rice, Associate Director at BCW Global.
Please share this article - Go to very top of page, right hand side, for social media buttons.
Lord Turner chairs the Energy Transitions Commission, a global coalition of major power and industrial companies, investors, environmental NGOs and experts working out achievable pathways to limit global warming to well below 2˚C by 2040 while stimulating economic development and social progress.
Australia
Shanghai
China
Sydney
New-south-wales
United-kingdom
House-of-lords
Singapore
Cambridge
Cambridgeshire
University-college
London
Compugen Reports First Quarter 2021 Results
USA - English
Updated data from COM701 Phase 1 combination and monotherapy studies to be presented at the American Society of Clinical Oncology (ASCO) 2021 Annual Meeting
Milestone rich 2021 to include data readouts from ongoing COM701 triple combination study and COM902 monotherapy study in Q4 2021
Initiation of Phase 1b cohort expansion study of COM701 with Opdivo® in Q2 2021 and Phase 1 COM701 with COM902 dual combination study in 2H 2021 will expand systematic DNAM axis clinical evaluation
News provided by
Share this article
Share this article
HOLON, Israel, May 13, 2021 /PRNewswire/ Compugen Ltd. (Nasdaq: CGEN), a clinical-stage cancer immunotherapy company and a leader in predictive target discovery, today reported financial results for the first quarter ended March 31, 2021.
United-states
Israel
Tel-aviv
American
John-mullaly
Johns-hopkins-university
Lifesci-advisors
Society-for-immunotherapy-of-cancer
American-society-of-clinical-oncology
Compugen-ltd
Compugen
Nasdaq